GBM Drug Bank—a new resource for glioblastoma drug discovery and informatics research

The availability of open access chemical databases associating compounds with their biological activities impacts fundamentally the early stages of modern drug discovery.¹ The increasing interest in both drug repurposing² and drug combination³ also necessitates the development of databases detailing compounds and mechanisms that have been explored previously.